1.Anaphylactic Reaction Induced by Diclofenac: A Case Report
Takuro Sanuki ; Shingo Sugioka ; Junichiro Kotani
Oral Science International 2009;7(1):34-36
An anaphylactic reaction is a most severe immune-mediated reaction. Diclofenac is a widely used non-steroidal anti-inflammatory drug (NSAID) derivative of phenylacetic acid, and continues to be routinely prescribed. We report a case of an anaphylactic reaction induced by oral diclofenac.
2.Trigeminovagal Reflex Caused by Stimulation of the Mandibular Division of the Trigeminal Nerve under General Anesthesia
Takuro Sanuki ; Naoko Yamamoto ; Mari Miki ; Shingo Sugioka ; Junichiro Kotani
Oral Science International 2009;6(2):109-111
We report a rare case of trigeminovagal reflex (TVR) resulting from stimulation of the mandibular division of the trigeminal nerve under general anesthesia. Although general anesthesia reportedly prevents TVR, it should be part of the differential diagnosis in all cases of unexplained sinus arrest during oral and maxillofacial surgery.
3.Comparison of the hemodynamic effects of propofol and ketamine as anesthetic induction agents during high-dose remifentanil administration: a single-center retrospective comparative study.
Takuro SANUKI ; Gaku MISHIMA ; Shinji KURATA ; Toshihiro WATANABE ; Kensuke KIRIISHI ; Mizuki TACHI ; Yu OZAKI ; Ichiro OKAYASU ; Mari KAWAI ; Yuki MATSUSHITA ; Keiichiro MIURA ; Takao AYUSE
Journal of Dental Anesthesia and Pain Medicine 2015;15(3):129-134
BACKGROUND: We hypothesized that ketamine, when administered as the anesthetic induction agent, may prevent cardiovascular depression during high-dose remifentanil administration, unlike propofol. To test our hypothesis, we retrospectively compared the hemodynamic effects of ketamine, during high-dose remifentanil administration, with those of propofol. METHODS: Thirty-eight patients who underwent oral surgery at the Nagasaki University Hospital between April 2014 and June 2015 were included in this study. Anesthesia was induced by the following procedure: First, high-dose remifentanil (0.3-0.5 µg/kg/min) was administered 2-3 min before anesthesia induction; next, the anesthetic induction agent, either propofol (Group P) or ketamine (Group K), was administered. Mean arterial pressure (MAP) and the heart rate were recorded by the automated anesthesia recording system at four time points: immediately before the administration of high-dose remifentanil (T1); immediately before the administration of propofol or ketamine (T2); 2.5 min (T3), and 5 min (T4) after the administration of the anesthetic induction agent. RESULTS: In Group P, the MAP at T3 (75.7 ± 15.5 mmHg, P = 0.0015) and T4 (68.3 ± 12.5 mmHg, P < 0.001) were significantly lower than those at T1 (94.0 ± 12.4 mmHg). However, the MAP values in the K group were very similar (P = 0.133) at all time points. The heart rates in both Groups P (P = 0.254) and K (P = 0.859) remained unchanged over time. CONCLUSIONS: We showed that ketamine, when administered as the anesthetic induction agent during high-dose remifentanil administration, prevents cardiovascular depression.
Anesthesia
;
Arterial Pressure
;
Depression
;
Heart Rate
;
Hemodynamics*
;
Humans
;
Ketamine*
;
Propofol*
;
Retrospective Studies*
;
Surgery, Oral
4.Comparison of the hemodynamic effects of propofol and ketamine as anesthetic induction agents during high-dose remifentanil administration: a single-center retrospective comparative study.
Takuro SANUKI ; Gaku MISHIMA ; Shinji KURATA ; Toshihiro WATANABE ; Kensuke KIRIISHI ; Mizuki TACHI ; Yu OZAKI ; Ichiro OKAYASU ; Mari KAWAI ; Yuki MATSUSHITA ; Keiichiro MIURA ; Takao AYUSE
Journal of Dental Anesthesia and Pain Medicine 2015;15(3):129-134
BACKGROUND: We hypothesized that ketamine, when administered as the anesthetic induction agent, may prevent cardiovascular depression during high-dose remifentanil administration, unlike propofol. To test our hypothesis, we retrospectively compared the hemodynamic effects of ketamine, during high-dose remifentanil administration, with those of propofol. METHODS: Thirty-eight patients who underwent oral surgery at the Nagasaki University Hospital between April 2014 and June 2015 were included in this study. Anesthesia was induced by the following procedure: First, high-dose remifentanil (0.3-0.5 µg/kg/min) was administered 2-3 min before anesthesia induction; next, the anesthetic induction agent, either propofol (Group P) or ketamine (Group K), was administered. Mean arterial pressure (MAP) and the heart rate were recorded by the automated anesthesia recording system at four time points: immediately before the administration of high-dose remifentanil (T1); immediately before the administration of propofol or ketamine (T2); 2.5 min (T3), and 5 min (T4) after the administration of the anesthetic induction agent. RESULTS: In Group P, the MAP at T3 (75.7 ± 15.5 mmHg, P = 0.0015) and T4 (68.3 ± 12.5 mmHg, P < 0.001) were significantly lower than those at T1 (94.0 ± 12.4 mmHg). However, the MAP values in the K group were very similar (P = 0.133) at all time points. The heart rates in both Groups P (P = 0.254) and K (P = 0.859) remained unchanged over time. CONCLUSIONS: We showed that ketamine, when administered as the anesthetic induction agent during high-dose remifentanil administration, prevents cardiovascular depression.
Anesthesia
;
Arterial Pressure
;
Depression
;
Heart Rate
;
Hemodynamics*
;
Humans
;
Ketamine*
;
Propofol*
;
Retrospective Studies*
;
Surgery, Oral